therapeutics - HoustonNewMedia.org https://houstonnewmedia.org/tag/therapeutics/ Building "Bridges" Across the Bayou City! Thu, 13 Nov 2025 23:17:17 +0000 en-US hourly 1 https://wordpress.org/?v=6.9 https://i0.wp.com/houstonnewmedia.org/wp-content/uploads/2022/11/cropped-cropped-Houston.png?fit=32%2C32&ssl=1 therapeutics - HoustonNewMedia.org https://houstonnewmedia.org/tag/therapeutics/ 32 32 103504436 Tvardi Therapeutics Q3 2025 Earnings: Loss Narrows, Beats Estimates – News and Statistics https://houstonnewmedia.org/tvardi-therapeutics-q3-2025-earnings-loss-narrows-beats-estimates-news-and-statistics/?utm_source=rss&utm_medium=rss&utm_campaign=tvardi-therapeutics-q3-2025-earnings-loss-narrows-beats-estimates-news-and-statistics Thu, 13 Nov 2025 23:17:17 +0000 http://houstonnewmedia.org/?guid=48affa43a5c6aee2612dceb86da1fb24 The Sugar Land, Texas-based company said it had a per-share loss of 59 cents. The results exceeded Wall Street expectations, with the average estimate ...

The post Tvardi Therapeutics Q3 2025 Earnings: Loss Narrows, Beats Estimates – News and Statistics first appeared on HoustonNewMedia.org.

The post Tvardi Therapeutics Q3 2025 Earnings: Loss Narrows, Beats Estimates – News and Statistics appeared first on HoustonNewMedia.org.

]]> 1062838 Tvardi Therapeutics Q3 2025 Earnings: Loss Narrows, Beats Estimates – News and Statistics https://houstonnewmedia.org/tvardi-therapeutics-q3-2025-earnings-loss-narrows-beats-estimates-news-and-statistics-2/?utm_source=rss&utm_medium=rss&utm_campaign=tvardi-therapeutics-q3-2025-earnings-loss-narrows-beats-estimates-news-and-statistics-2 Thu, 13 Nov 2025 23:17:17 +0000 http://houstonnewmedia.org/?guid=0264367130b62a18f1de4c6f41e1273c The Sugar Land, Texas-based company said it had a per-share loss of 59 cents. The results exceeded Wall Street expectations, with the average estimate ...

The post Tvardi Therapeutics Q3 2025 Earnings: Loss Narrows, Beats Estimates – News and Statistics first appeared on HoustonNewMedia.org.

The post Tvardi Therapeutics Q3 2025 Earnings: Loss Narrows, Beats Estimates – News and Statistics appeared first on HoustonNewMedia.org.

]]> 1062971 Tvardi Therapeutics to go public in reverse merger with Connecticut company – Houston … https://houstonnewmedia.org/tvardi-therapeutics-to-go-public-in-reverse-merger-with-connecticut-company-houston/?utm_source=rss&utm_medium=rss&utm_campaign=tvardi-therapeutics-to-go-public-in-reverse-merger-with-connecticut-company-houston Wed, 18 Dec 2024 21:30:47 +0000 http://houstonnewmedia.org/?guid=726a240345190d05f1ac2ab09cdf5d01 Tvardi Therapeutics, a Sugar Land-based pharmaceutical company co-founded by a former MD Anderson president, will hit the stock market early next ...

The post Tvardi Therapeutics to go public in reverse merger with Connecticut company – Houston … first appeared on HoustonNewMedia.org.

The post Tvardi Therapeutics to go public in reverse merger with Connecticut company – Houston … appeared first on HoustonNewMedia.org.

]]> 864007 SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit https://houstonnewmedia.org/sage-investors-have-opportunity-to-lead-sage-therapeutics-inc-securities-fraud-lawsuit/?utm_source=rss&utm_medium=rss&utm_campaign=sage-investors-have-opportunity-to-lead-sage-therapeutics-inc-securities-fraud-lawsuit Sat, 31 Aug 2024 23:20:21 +0000 http://houstonnewmedia.org/?guid=400ff1b75535d8ddfaa829cb84dba02e SUGAR LAND, Texas, Aug. 31, 2024 /PRNewswire/ -- Noble Corporation plc ("Noble") (NYSE: NE, CSE: NOBLE)… 3 hours ago. PR Newswire · Scientology ...

The post SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit first appeared on HoustonNewMedia.org.

The post SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit appeared first on HoustonNewMedia.org.

]]> 813306 Celltex Therapeutics Corporation hiring Quality Control Technician in Sugar Land, Texas … https://houstonnewmedia.org/celltex-therapeutics-corporation-hiring-quality-control-technician-in-sugar-land-texas/?utm_source=rss&utm_medium=rss&utm_campaign=celltex-therapeutics-corporation-hiring-quality-control-technician-in-sugar-land-texas Mon, 01 Nov 2021 01:11:18 +0000 http://houstonnewmedia.org/?guid=f1f02e69b768c7fbde900e17d2be45e5 Actual pay may be different — this range is estimated based on Quality Control Technician in Sugar Land, Texas, United States at similar companies ...

The post Celltex Therapeutics Corporation hiring Quality Control Technician in Sugar Land, Texas … first appeared on HoustonNewMedia.org.

The post Celltex Therapeutics Corporation hiring Quality Control Technician in <b>Sugar Land</b>, <b>Texas</b> … appeared first on HoustonNewMedia.org.

]]> 193981 Celltex Therapeutics Corporation hiring Quality Control Technician in Sugar Land, Texas … https://houstonnewmedia.org/celltex-therapeutics-corporation-hiring-quality-control-technician-in-sugar-land-texas-2/?utm_source=rss&utm_medium=rss&utm_campaign=celltex-therapeutics-corporation-hiring-quality-control-technician-in-sugar-land-texas-2 Mon, 01 Nov 2021 01:11:18 +0000 http://houstonnewmedia.org/?guid=09430e7940728f4f91d3bf5b980a30f6 Actual pay may be different — this range is estimated based on Quality Control Technician in Sugar Land, Texas, United States at similar companies ...

The post Celltex Therapeutics Corporation hiring Quality Control Technician in Sugar Land, Texas … first appeared on HoustonNewMedia.org.

The post Celltex Therapeutics Corporation hiring Quality Control Technician in <b>Sugar Land</b>, Texas … appeared first on HoustonNewMedia.org.

]]> 194025 Biopharmaceutical co. Tvardi Therapeutics raises $74M to advance clinical pipeline, grow team https://houstonnewmedia.org/biopharmaceutical-co-tvardi-therapeutics-raises-74m-to-advance-clinical-pipeline-grow-team/?utm_source=rss&utm_medium=rss&utm_campaign=biopharmaceutical-co-tvardi-therapeutics-raises-74m-to-advance-clinical-pipeline-grow-team Wed, 23 Jun 2021 18:23:14 +0000 http://houstonnewmedia.org/?guid=2e399ebbaa4699813745e3d8f9628cfc The Houston firm's scientific advisory has ties to scientists at the M.D. Anderson Cancer Center.

The post Biopharmaceutical co. Tvardi Therapeutics raises $74M to advance clinical pipeline, grow team first appeared on HoustonNewMedia.org.

The post Biopharmaceutical co. Tvardi Therapeutics raises $74M to advance clinical pipeline, grow team appeared first on HoustonNewMedia.org.

]]> 136548 Stellanova Therapeutics hiring, advancing clinical pipeline after $15.5M raise https://houstonnewmedia.org/stellanova-therapeutics-hiring-advancing-clinical-pipeline-after-15-5m-raise/?utm_source=rss&utm_medium=rss&utm_campaign=stellanova-therapeutics-hiring-advancing-clinical-pipeline-after-15-5m-raise Sun, 06 Jun 2021 12:00:00 +0000 http://houstonnewmedia.org/?guid=7f0771e2d16892ae65ef53f9db81c108 A Houston-based biotechnology firm plans to hire and develop a new discovery platform for its cancer therapeutics after a Series A raise.

Stellanova Therapeutics is developing an antibody that targets fiber blast cells, which protect cancer cells aga...

The post Stellanova Therapeutics hiring, advancing clinical pipeline after $15.5M raise first appeared on HoustonNewMedia.org.

The post Stellanova Therapeutics hiring, advancing clinical pipeline after $15.5M raise appeared first on HoustonNewMedia.org.

]]> 132682 Biotech firm Stellanova Therapeutics closes $15.5M Series A, names CEO https://houstonnewmedia.org/biotech-firm-stellanova-therapeutics-closes-15-5m-series-a-names-ceo/?utm_source=rss&utm_medium=rss&utm_campaign=biotech-firm-stellanova-therapeutics-closes-15-5m-series-a-names-ceo Wed, 02 Jun 2021 21:05:11 +0000 http://houstonnewmedia.org/?guid=ae2769e3822c061c28527b9d5a97ae0e Houston-based biotechnology firm Stellanova Therapeutics raised $15.5 million to advance development of its cancer therapies.

The Series A round was led by Houston-based Sporos Bioventures LLC, Stellanova announced June 3.

Stellanova is developing ...

The post Biotech firm Stellanova Therapeutics closes $15.5M Series A, names CEO first appeared on HoustonNewMedia.org.

The post Biotech firm Stellanova Therapeutics closes $15.5M Series A, names CEO appeared first on HoustonNewMedia.org.

]]> 131963 Biotech firm Asylia Therapeutics raises $14.5M, names founding CEO https://houstonnewmedia.org/biotech-firm-asylia-therapeutics-raises-14-5m-names-founding-ceo/?utm_source=rss&utm_medium=rss&utm_campaign=biotech-firm-asylia-therapeutics-raises-14-5m-names-founding-ceo Tue, 25 May 2021 18:03:16 +0000 http://houstonnewmedia.org/?guid=66531b23c7851637ce9445b23f429075 Houston-based biotechnology firm Asylia Therapeutics Inc. raised $14.5 million to advance its clinical trials for cancer drugs.

The Series A round was led by Houston-based Sporos Bioventures, Asylia announced May 25. The company will use proceeds to ...

The post Biotech firm Asylia Therapeutics raises $14.5M, names founding CEO first appeared on HoustonNewMedia.org.

The post Biotech firm Asylia Therapeutics raises $14.5M, names founding CEO appeared first on HoustonNewMedia.org.

]]> 130108 Athenex acquires Houston biotech co. Kuur Therapeutics for $185M https://houstonnewmedia.org/athenex-acquires-houston-biotech-co-kuur-therapeutics-for-185m/?utm_source=rss&utm_medium=rss&utm_campaign=athenex-acquires-houston-biotech-co-kuur-therapeutics-for-185m Wed, 05 May 2021 18:33:14 +0000 http://houstonnewmedia.org/?guid=8077b0b207cd874d0c0d35f19a806404 Kuur Therapeutics develops cellular immunotherapies targeting cancer using a platform created by a Baylor College of Medicine and Texas Children's Hospital researcher.

The post Athenex acquires Houston biotech co. Kuur Therapeutics for $185M first appeared on HoustonNewMedia.org.

The post Athenex acquires Houston biotech co. Kuur Therapeutics for $185M appeared first on HoustonNewMedia.org.

]]> 126225 Houston oncology co. Iterion Therapeutics raises $17M for clinical trials https://houstonnewmedia.org/houston-oncology-co-iterion-therapeutics-raises-17m-for-clinical-trials/?utm_source=rss&utm_medium=rss&utm_campaign=houston-oncology-co-iterion-therapeutics-raises-17m-for-clinical-trials Mon, 22 Feb 2021 19:41:01 +0000 http://houstonnewmedia.org/?guid=9a943761a283151382f0dc6ad6d438c8 Iterion Therapeutics is investigating its lead clinical candidate, Tegavivint, in a Phase 1/2a clinical trial in patients with desmoid turmors.

The post Houston oncology co. Iterion Therapeutics raises $17M for clinical trials first appeared on HoustonNewMedia.org.

The post Houston oncology co. Iterion Therapeutics raises $17M for clinical trials appeared first on HoustonNewMedia.org.

]]> 111470